252 related articles for article (PubMed ID: 17660250)
1. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
[TBL] [Abstract][Full Text] [Related]
2. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
Lee MH; Rapti M; Knaüper V; Murphy G
J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
[TBL] [Abstract][Full Text] [Related]
3. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
[TBL] [Abstract][Full Text] [Related]
4. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
Wei S; Chen Y; Chung L; Nagase H; Brew K
J Biol Chem; 2003 Mar; 278(11):9831-4. PubMed ID: 12515831
[TBL] [Abstract][Full Text] [Related]
5. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1.
Iyer S; Wei S; Brew K; Acharya KR
J Biol Chem; 2007 Jan; 282(1):364-71. PubMed ID: 17050530
[TBL] [Abstract][Full Text] [Related]
7. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.
Meng Q; Malinovskii V; Huang W; Hu Y; Chung L; Nagase H; Bode W; Maskos K; Brew K
J Biol Chem; 1999 Apr; 274(15):10184-9. PubMed ID: 10187802
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2003 Oct; 278(41):40224-30. PubMed ID: 12869573
[TBL] [Abstract][Full Text] [Related]
9. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.
Batra J; Robinson J; Soares AS; Fields AP; Radisky DC; Radisky ES
J Biol Chem; 2012 May; 287(19):15935-46. PubMed ID: 22427646
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
Batra J; Soares AS; Mehner C; Radisky ES
PLoS One; 2013; 8(9):e75836. PubMed ID: 24073280
[TBL] [Abstract][Full Text] [Related]
12. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
[TBL] [Abstract][Full Text] [Related]
13. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.
Lee MH; Atkinson S; Rapti M; Handsley M; Curry V; Edwards D; Murphy G
Cancer Lett; 2010 Apr; 290(1):114-22. PubMed ID: 19815335
[TBL] [Abstract][Full Text] [Related]
14. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
15. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
16. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
Huang W; Meng Q; Suzuki K; Nagase H; Brew K
J Biol Chem; 1997 Aug; 272(35):22086-91. PubMed ID: 9268350
[TBL] [Abstract][Full Text] [Related]
17. Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10.
Raeeszadeh-Sarmazdeh M; Coban M; Mahajan S; Hockla A; Sankaran B; Downey GP; Radisky DC; Radisky ES
J Biol Chem; 2022 Mar; 298(3):101654. PubMed ID: 35101440
[TBL] [Abstract][Full Text] [Related]
18. Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy.
Jiang B; Liu J; Lee MH
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641935
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
